Gelteq GELS
NASDAQ GELS
$0.79 -0.06 (-7.37%)
At close: Sep 10, 2026 · 4:00 PM EDT

Gelteq (GELS) Common Equity (2023 - 2025)

Gelteq (GELS) posted Common Equity of $9.3 million for Q4 2025, down 7.88% on a QoQ basis from $10.1 million in Q2 2025, and down 24.13% year-over-year from $12.3 million in Q4 2024.

Analysis

Gelteq (GELS) Common Equity (2023 - 2025) Analysis & Trends

Gelteq has reported Common Equity for 3 years, with the latest figure at $9.3 million in Q4 2025.

  • On a quarterly basis, Common Equity fell 24.13% year-over-year to $9.3 million in Q4 2025; TTM through Dec 2025 was $9.3 million, a 24.13% decrease from a year earlier, with the FY2025 full-year figure at $10.1 million, up 2.12% from the prior year.
  • Common Equity was $9.3 million for Q4 2025 at Gelteq, down from $10.1 million in the prior quarter.
  • The five-year high for Common Equity was $12.5 million in Q2 2023, with the low at $9.3 million in Q4 2025.
  • Average Common Equity over 3 years is $10.8 million, with a median of $10.1 million recorded in 2025.
  • The largest YoY upside for Common Equity was 1.63% in 2025 against a maximum downside of 24.13% in 2025.
  • Over 3 years, Common Equity stood at $12.5 million in 2023, then slipped by 1.45% to $12.3 million in 2024, then retreated by 24.13% to $9.3 million in 2025.
  • The last three Common Equity figures came in at $9.3 million (Q4 2025), $10.1 million (Q2 2025), and $12.3 million (Q4 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Natural Alternatives International 12.05 Mn 2.78 Mn 383,000.00 63.11 Mn
2 Gelteq 7.42 Mn 7.37 Mn - 9.32 Mn
3 Nexgel 121,250.28 -1.07 Mn 1.11 Mn 5.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 9.32 Mn
Jun 30, 2025 10.12 Mn
Dec 31, 2024 12.29 Mn
Jun 30, 2024 9.96 Mn
Jun 30, 2023 12.47 Mn